Incyte Corp (FRA:ICY)
€ 49.53 -0.85 (-1.69%) Market Cap: 11.18 Bil Enterprise Value: 7.64 Bil PE Ratio: 16.22 PB Ratio: 2.23 GF Score: 84/100

Incyte Corp at William Blair Growth Stock Conference (Virtual) Transcript

Jun 03, 2021 / 05:00PM GMT
Release Date Price: €67.46 (-0.41%)
Matthew Christopher Phipps
William Blair & Company L.L.C., Research Division - Senior Biotechnology Research Analyst

Hi, my name is Matt Phipps. I'm a Research Analyst here at William Blair covering Incyte. And just before we get things kicked off, I do have to say, please visit williamblair.com for a list of any disclosures or conflicts of interest. And I'm happy to have with us Christiana Stamoulis, the Chief Financial Officer; and Steve -- Steven Stein, Chief Medical Officer to talk about kind of the growth of Jakafi and the expanding business at Incyte.

And since we only have 30 minutes here, I'm going to jump right into questions and talking about the company.

Questions & Answers

Matthew Christopher Phipps
William Blair & Company L.L.C., Research Division - Senior Biotechnology Research Analyst

So Christiana, I wonder if you could start us off, talk about Jakafi, a bit of a lighter first quarter, but still maintaining full year guidance.

So how do you feel now about the COVID-19 impact and being able to hit that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot